Emily Davies

Associate

Emily is an associate in the commercial, IP and IT team in London. She assists corporate and life sciences clients on a broad variety of contentious and non-contentious matters. She is a member of the firm’s media and creative industries, sports and life sciences sector groups.

On the non-contentious side, Emily assists on a range of commercial agreements. In particular, her practice covers drafting and advising on master services agreements, general terms and conditions to the supply of goods and services and IT contracts. She also assists with non-contentious IP matters, including drafting and negotiating patent and know-how licences, and copyright licences.

I enjoy the variety that my practice affords me, advising on both contentious and non-contentious commercial and intellectual property matters. While the matters may differ, my approach is to give technical but pragmatic advice.

Emily Davies, Associate

Emily’s contentious practice focuses on IP. She assists on intellectual property disputes matters including patents, copyright and trade marks. She has advised clients on claims before the Patents Court and the Intellectual Property Enterprise Court (IPEC).

Having joined as a trainee in 2022, Emily qualified with the firm in 2024. Prior to her training contract, Emily obtained her undergraduate degree in geography, before completing the Graduate Diploma in Law (GDL) and Legal Practice Course (LPC). She was previously a commercial paralegal at a multinational electric vehicle charging company.

Recent work highlights

Patents Court proceedings

Representing Cipla, one of multiple claimants, in legal proceedings in the Patents Court relating to the invalidity of the anticoagulant rivaroxaban.

Assisting not-for-profits

Advising a not-for-profit publishing organisation on an international services agreement.

Life sciences regulatory advice

Advising an international pharmaceutical company on the UK life sciences regulatory landscape.

Data protection for healthtech

Advising a global healthtech company on the data protection aspects of its clinical trial solutions.